Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 2020

View Archived Issues

Preclinical pilot study data presented for NX-P004 programme in IPF

Bristol-Myers Squibb identifies MGAT2 inhibitors for metabolic disorders

Tyrosine kinase controls AD tau aggregation in vivo

A novel thermally stable mRNA vaccine candidate protects mice against SARS-CoV-2 challenge

Islet organoids can evade immune attack

NSC-801845, a novel cytidine analogue with excellent activity in number of tumor models

First-in-human data presented for the live-attenuated RSV vaccine, RSVdeltaG

Janssen presents new anti-influenza nucleosides

New CDK2/cyclin E inhibitors discovered at Pfizer

Velexbru granted supplemental approval in Japan

Femtogenix discloses G-A crosslinking cytotoxic agents

New KDM1A inhibitors synthesized at Hanmi Science

Jiangsu Chia Tai Tianqing Pharmaceutical, Medshine Discovery patent PARP-1 inhibitors

FDA approves Xeomin for its first pediatric indication

Mechanisms of retinopathy come into focus

Targeting SARS-CoV-2 papain-like protease suppresses viral infection and promotes antiviral immunity

Opthea completes meeting with FDA and EMA for phase III clinical program of OPT-302 in wet AMD

First-in-class anticancer therapy ErSO targets estrogen receptor alpha-positive breast cancer

Roche begins phase II study of GDC-9545 for postmenopausal women with untreated early breast cancer

European Commission approves Kaftrio with ivacaftor for cystic fibrosis